| Autor: |
Antoni Bayes‐Genis, Gordana Krljanac, Marija Zdravković, Milika Ašanin, Anastazija Stojšić‐Milosavljević, Slavica Radovanović, Tamara Preradović Kovačević, Aleksandar Selaković, Ivan Milinković, Marija Polovina, Duška Glavaš, Elizabeta Srbinovska, Nebojša Bulatović, Davor Miličić, Maja Čikeš, Zdravko Babić, Jozica Šikić, Zumreta Kušljugić, Larisa Dizdarević Hudić, Henrike Arfsten, Laura M.G. Meems, Marco Metra, Giuseppe Rosano, Petar M. Seferović, Young Investigators of the Peptide for Life Initiative |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
ESC Heart Failure, Vol 11, Iss 2, Pp 672-680 (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2055-5822 |
| DOI: |
10.1002/ehf2.14625 |
| Popis: |
Abstract Aims Natriuretic peptide (NP) uptake varies in Emergency Departments (EDs) across Europe. The ‘Peptide for Life’ (P4L) initiative, led by Heart Failure Association, aims to enhance NP utilization for early diagnosis of heart failure (HF). We tested the hypothesis that implementing an educational campaign in Western Balkan countries would significantly increase NP adoption rates in the ED. Methods and results This registry examined NP adoption before and after implementing the P4L‐ED study across 10 centres in five countries: Bosnia and Herzegovina, Croatia, Montenegro, North Macedonia, and Serbia. A train‐the‐trainer programme was implemented to enhance awareness of NP testing in the ED, and centres without access received point‐of‐care instruments. Differences in NP testing between the pre‐P4L‐ED and post‐P4L‐ED phases were evaluated. A total of 2519 patients were enrolled in the study: 1224 (48.6%) in the pre‐P4L‐ED phase and 1295 (51.4%) in the post‐P4L‐ED phase. NP testing was performed in the ED on 684 patients (55.9%) during the pre‐P4L‐ED phase and on 1039 patients (80.3%) during the post‐P4L‐ED phase, indicating a significant absolute difference of 24.4% (95% CI: 20.8% to 27.9%, P |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
Plný text